Oncimmune has announced another ImmunoINSIGHTS contract win with a Top-ten pharmaceutical partner. This is the fourth partnership agreement announced in four months, and shows significant industry interest in the SeroTag autoantibody library technology and adds confidence to revenue expectations for FY’21. We believe that the agreement today alongside the significant follow-on contract with Roche announced in June shows clear industry engagement and momentum. Service revenues are typica
02 Sep 2020
Latest big pharma contract adds confidence to FY’21e revenues
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Latest big pharma contract adds confidence to FY’21e revenues
Oncimmune Holdings Plc (ONC:LON) | 21.2 0 0.0% | Mkt Cap: 15.7m
- Published:
02 Sep 2020 -
Author:
Edward Thomason -
Pages:
3
Oncimmune has announced another ImmunoINSIGHTS contract win with a Top-ten pharmaceutical partner. This is the fourth partnership agreement announced in four months, and shows significant industry interest in the SeroTag autoantibody library technology and adds confidence to revenue expectations for FY’21. We believe that the agreement today alongside the significant follow-on contract with Roche announced in June shows clear industry engagement and momentum. Service revenues are typica